This variant was judged to be pathogenic by application of the following criteria: PVS1 (predicted loss of function allele), PS2 (de novo, see below), PS4 (previously reported in several individuals with microphthalmia or anophthalmia) and PM2 (not found in gnomAD) (12,13). This evidence concerns the gene TAS2R18P and microphthalmia.